Protective effect of Hachimi-jio-gan against renal failure in a subtotal nephrectomy rat model

Journal of Pharmacy and Pharmacology

Volumn 57, Issue 12, 2005, Pages 1637-1644

  Yamabe, Noriko ^a   Yokozawa, Takako ^a   Kim, Hyun Young ^a   Cho, Eun Ju ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CATALASE; CREATININE; GLUTATHIONE PEROXIDASE; HACHIMIJIOGAN; HYDROXYL RADICAL; METHYLGUANIDINE; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE CLEARANCE; ENZYME ACTIVITY; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HYALINE DEGENERATION; INFLAMMATION; KIDNEY FIBROSIS; KIDNEY MASS; MALE; NONHUMAN; OXIDATIVE STRESS; PARTIAL NEPHRECTOMY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEINURIA; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL; UREMIA;

ANIMALS; BODY WEIGHT; DRUGS, CHINESE HERBAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; KIDNEY FAILURE; MALE; MODELS, ANIMAL; NEPHRECTOMY; ORGAN SIZE; PROTEINURIA; RATS; RATS, WISTAR;

EID: 28644443212     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.57.12.0014     Document Type: Article

References (37)

1. Aebi, H. (1974) Catalase. In: Bergmeyer, H. U. (ed) Methods of enzymatic analysis. Verlag Chemie, New York, pp 673-684
2. Brenner, B. M. (1985) Nephron adaptation to renal injury or ablation. Am. J. Physiol. 249: F324-F337
3. Brenner, B. M., Meyer, T. W., Hostetter, T. H. (1982) Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N. Engl. J. Med. 307: 652-659
4. Chertow, G. M., Bullard, A., Lazarus, J. M. (1996) Nutrition and the dialysis prescription. Am. J. Nephrol. 16: 79-89
5. De Deyn, P. P., Vanholder, R., D'Hooge, R. (2003) Nitric oxide in uremia: effect of several potentially toxic guanidine compounds. Kidney Int. 84: S25-S28
6. Elstner, E. F., Heupel, A. (1976) Inhibition of nitrite formation from hydroxylammoniumchloride: a simple assay for superoxide dismutase. Anal. Biochem. 70: 616-620
7. Fantone, J. C., Ward, P. A. (1982) Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am. J. Pathol. 107: 395-418
8. Furuya, Y., Kawakita, T., Tajima, S. (1999) Effect of Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) on insulin resistance in non-insulin dependent diabetes mellitus model mice. J. Trad. Med. 16:123-128
9. Goto, M., Inoue, H., Seyama, Y., Yamashita, S., Inoue, O., Yumioka, E. (1989) Comparative effects of traditional Chinese medicines (Dai-saiko-to, Hatimi-zio-gan and Byakko-ka-ninzin-to) on experimental diabetes and hyperlipidemia. Nippon Yakurigaku Zasshi 93: 179-186
10. Hafeman, D. G., Sunde, R. A., Hoekstra, W. G. (1974) Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J. Nutr. 104: 580-587
11. Harris, D. C., Chan, L., Schrier, R. W. (1988) Remnant kidney hypermetabolism and progression of chronic renal failure. Am. J. Physiol. 254: F267-F276
12. Higashidate, S., Maekubo, T., Saito, M., Senda, M., Hoshino, T. (1984) Rapid and highly sensitive method for the determination of guanidine compounds in body fluids. Bunseki Kagaku 33: 366-370
13. Hijikata, Y., Nasu, M., Tsukamoto, Y. (1994) Alternative treatment for nephrotic syndrome using Ba-Wei-Di-Huang-Wan. J. Trad. Med. 11: 29-37
14. Hikiami, H., Shibahara, N., Goto, H., Kogure, T., Nagasaka, K., Kita, T., Shimada, Y., Itoh, T., Terasawa, K. (2000) Effects of Kampo treatment on the development and progression of diabetic microangiopathy. J. Jpn. Soc. Orient. Med. 50: 841-850
15. Himmelfarb, J., McMonagle, E. (2001) Albumin in the major plasma protein target of oxidant stress in uremia. Kidney Int. 60: 358-363
16. Hirawa, N., Uehara, Y., Kawabata, Y., Numabe, A., Takada, S., Nagoshi, H., Gomi, T., Ikeda, T., Omata, M. (1996) Hachimi-jio-gan extract protects the kidney from hypertensive injury in Dahl salt-sensitive rat. Am. J. Chin. Med. 24: 241-254
17. Hostetter, T. H., Olson, J. L., Rennke, H. G., Venkatachalam, M. A., Brenner, B. M. (1981) Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am. J. Physiol. 241: F85-F93
18. Huang, T. (1997) A handbook of traditional Chinese prescriptions of dubious and complicated cases. China Medical and Pharmaceutical Science and Technology Publishing House, Beijing, pp 527-538
19. Itzhaki, R. F., Gill, D. M. (1964) A micro-biuret method for estimating proteins. Anal. Biochem. 121: 401-410
20. Marescau, B., Deshmukh, D. R., Kockx, M., Possemiers, I., Qureshi, I. A., Wiechert, P., De Deyn, P. P. (1992) Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals. Metabolism 41: 526-532
21. Mitsuma, T. (1996) Preventive effects of Eastern medication (Kampo) on the progression of chronic renal failure. Int. J. Urol. 3: S95-S100
22. Morrison, A. B. (1966) Experimental chronic renal insufficiency. Methods Achiev. Exp. Pathol. 1: 455-475
23. Nagase, S., Aoyagi, K., Narita, M., Tojo, S. (1985) Biosynthesis of methylguanidine in isolated rat hepatocytes and in vivo. Nephron 40: 470-475
24. Nagase, S., Aoyagi, K., Narita, M., Tojo, S. (1986) Active oxygen in methylguanidine synthesis. Nephron 44: 299-303
25. Nakagawa, T., Yokozawa, T., Terasawa, K. (2001) A study of Kampo medicines in a diabetic nephropathy model. J. Trad. Med. 18: 161-168
26. Nakamura, K., Ienaga, K., Yokozawa, T., Fujitsuka, N., Oura, H. (1991) Production of methylguanidine from creatinine via creatol by active oxygen species: analyses of the catabolism in vitro. Nephron 58: 42-46
27. Oyanagui, Y. (1984) Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. Anal. Biochem. 142: 290-296
28. Platt, R., Roscoe, M. H., Smith, F. W. (1952) Experimental renal failure. Clin. Sci. 11: 217-231
29. Remuzzi, G., Bertani, T. (1998) Pathophysiology of progressive nephropathies. N. Engl. J. Med. 339: 1448-1456
30. Remuzzi, G., Ruggenenti, P., Benigni, A. (1997) Understanding the nature of renal disease progression. Kidney Int. 51: 2-15
31. Rister, M., Baehner, R. L. (1976) The alteration of superoxide dismutase, catalase, glutathione peroxidase, and NAD(P)H cytochrome c reductase in guinea pig polymorphonuclear leukocytes and alveolar macrophages during hyperoxia. J. Clin. Invest. 58: 1174-1184
32. Sakagisi, Y. (1968) Total protein. In: Saito, M., Kitamura, M., Niwa, M. (eds) Rinsyo Kagaku Bunseki II. Tokyo Kagaku Dojin, Tokyo, pp 115-142
33. Sanaka, T., Higuchi, C., Omata, M. (1991) Active oxygen as the progressive factor of chronic renal failure. Renal Failure 3: 73-77
34. Schrier, R. W., Harris, D. C., Chan, L., Shapiro, J. I., Caramelo, C. (1988) Tubular hypermetabolism as a factor in the progression of chronic renal failure. Am. J. Kidney Dis. 12: 243-249
35. Yamada, T. (1992) Kinki Youryaku. Kyouwa-Kikaku, Tokyo, pp 1-7
36. Yokozawa, T., Dong, E., Oura, H., Kashiwagi, H., Nonaka, G., Nishioka, I. (1997) Magnesium lithospermate B suppresses the increase of active oxygen in rats after subtotal nephrectomy. Nephron 75: 88-93
37. Yokozawa, T., Yamabe, N., Cho, E. J., Nakagawa, T., Oowada, S. (2004) A study on the effects to diabetic nephropathy of Hachimi-jio-gan in rats. Nephron Exp. Nephrol. 97: e38-e48